Daily Northern

Nordic News, Every Day

Menu

Finnish Researchers Develop Breakthrough Method for Safe Cell Treatment, Potentially Revolutionizing Disease Treatment

Tuesday 9th 2024 on 12:05 in  
Finland

Researchers in Finland have successfully created cells that cannot turn into cancer cells. This method allows for a new type of safe cell treatment, according to the University of Helsinki.

The method was developed by researchers from the University of Helsinki and the Helsinki University Hospital. They were successful in creating cells whose division can be controlled. This could potentially be beneficial in hundreds of diseases. The University of Helsinki suggests that such cell treatments could be used in treating heart attacks, for example.

Currently, new cells are already being given to people with many blood diseases. Diabetes has also been treated by transplanting cells from organ donations. Recently, diabetes has also been treated with beta cells modified from the patient’s own stem cells.

However, genetically modified cells expose the patient to DNA changes that can increase the risk of cancer. Transferring cells between people is also complicated, due to variations in human tissue types. Researchers have been able to create cells that the human immune system does not recognize, suitable for everyone. However, these cells also carry an increased risk of cancer.

The solution provided by the research team allows for the efficient growth of cells and halting their growth when necessary. Furthermore, cells can be modified without the fear of side effects. They can be made in such a way that the human immune system does not recognize them.

“Previously, such cells would have been very risky, as the immune defense also monitors the emergence of cancer. Now that risk is very small or non-existent,” says Kirmo Wartiovaara, supervisor of the research team at the University of Helsinki.

Ideally, Wartiovaara believes the cells could be made into products that are suitable for everyone and can be quickly used when needed. The invention of the research team is protected by a patent.